GHC Stock Overview
Operates healthcare clinics in Italy. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Garofalo Health Care S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €5.76 |
| 52 Week High | €5.78 |
| 52 Week Low | €4.34 |
| Beta | 0.42 |
| 11 Month Change | 2.86% |
| 3 Month Change | 9.92% |
| 1 Year Change | 30.02% |
| 33 Year Change | -1.37% |
| 5 Year Change | 11.84% |
| Change since IPO | 62.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| GHC | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 4.7% | 0.1% | -0.02% |
| 1Y | 30.0% | 17.2% | 8.2% |
Return vs Industry: GHC exceeded the German Healthcare industry which returned 15.7% over the past year.
Return vs Market: GHC exceeded the German Market which returned 7.4% over the past year.
Price Volatility
| GHC volatility | |
|---|---|
| GHC Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: GHC has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: GHC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 2,770 | Maria Garofalo | www.garofalohealthcare.com |
Garofalo Health Care S.p.A., together with its subsidiaries, operates healthcare clinics in Italy. It operates through Hospital and Social/Dependency Care segments. The company offers high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and nutritional rehabilitation.
Garofalo Health Care S.p.A. Fundamentals Summary
| GHC fundamental statistics | |
|---|---|
| Market cap | €522.52m |
| Earnings (TTM) | €20.92m |
| Revenue (TTM) | €450.33m |
25.0x
P/E Ratio1.2x
P/S RatioIs GHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GHC income statement (TTM) | |
|---|---|
| Revenue | €450.33m |
| Cost of Revenue | €357.52m |
| Gross Profit | €92.82m |
| Other Expenses | €71.89m |
| Earnings | €20.92m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 20.61% |
| Net Profit Margin | 4.65% |
| Debt/Equity Ratio | 70.4% |
How did GHC perform over the long term?
See historical performance and comparison